Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toxys is a Dutch biotech company and contract research organization (CRO) that specializes in the development of innovative in vitro toxicity assays for the pharmaceutical, chemical, and cosmetic industries. The company's flagship technology, ToxTracker, is a unique reporter-based assay that provides mechanistic insight into the genotoxic properties of novel compounds by monitoring cellular stress responses. Beyond genotoxicity, Toxys offers specialized platforms for developmental toxicity (ReproTracker) and skin sensitization, helping clients mitigate risk early in the drug development process. By providing high-throughput, animal-free testing solutions, Toxys enables more accurate human risk assessment and supports the global shift toward New Approach Methodologies (NAMs) in toxicology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toxis.